Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a WhatsApp nudge or a Goal-Setting trick help diabetes patients stick to their meds?

NCT ID NCT07837856

Disease control Sponsor: Instituto Mexicano del Seguro Social Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 24, 2026 · Last updated Sep 25, 2026 · Updated 1 time

Summary

Researchers compare two ways to help people with type 2 diabetes follow their treatment plans. One group receives motivational and educational messages through WhatsApp, while the other learns to set specific, measurable goals using the SMART method. The study enrolls 250 adults aged 35 to 70 at a primary care clinic in Mexico. The team measures adherence with a questionnaire and tracks medication use and blood sugar levels.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
WhatsApp motivational messages and SMART goal-setting
What this could lead to
If one approach works better, clinics could use it to help patients with type 2 diabetes take their medicines more consistently.
What could go wrong
This is a small, non-randomized study in one clinic, so the results may not apply broadly. People may also change their habits simply because they are being watched.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

250 people

The number who actually took part.

Started

Nov 2024

Finished

Dec 2025

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * • Patients with type 2 diabetes mellitus. * Patients enrolled in UMF 84. * Men and women between the ages of 35 and 70. * Patients who agree to participate, understand the informed consent form, and sign it. * Patients who have a cell phone and the WhatsApp app. Exclusion Criteria: * • Patients with type 1 diabetes mellitus. * Patients with dementia, schizophrenia, alcoholism, drug addiction, cancer, Parkinson's disease, hearing and vision impairments, and comprehension and language disorders. * Pregnant patients. * Patients who cannot read or write. Exclusion Criteria * Patients who withdraw their consent. * Patients who fail to attend laboratory tests, questionnaire administration, or regular medical appointments. * Patient death. * Changes in health insurance enrollment. * Loss of health insurance coverage.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabete type 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus Treatment Adherence and Compliance type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabete type 2 Diabetes mellitus, type 2/prevention & control Treatment adherence

Contacts and locations

Locations

  • Family Medicine Unit No. 84

    Morelia, Michoacán, 58332, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.